Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
PORTABLE DEVICE AND METHOD FOR VAPORIZING MATERIALS
Publication number: 20190014824
Abstract: A portable device, and more particularly a portable device for vaporizing materials such as oils for inhalation. Also, methods for vaporizing materials and methods of operating portable vaporizing devices. In addition, networks for providing operational features and/or instructions for operation of vaporizing devices and for monitoring and collecting operational data. In preferred embodiments, a vaporizing device and/or methods for operating a vaporizing device wherein the vaporizing device includes one or more of the following features: security features to regulate operation of the device; automatic detection of vaporizing material identity; user experience monitoring and data collection; and/or temperature adjustment of vaporizing material based on detected material for vaporization.
Type: Application
Filed: November 21, 2017
Publication date: January 17, 2019
Inventors: Daniel Yazbeck, Joshua Londano, James Panther, Jason Panther
https://patents.justia.com/inventor/daniel-yazbeck?fbclid=IwAR3UrUz5kPH_YRaYvRl7rF_rrk79Xuj1viP3-YG0c8h60_GAtkKg_KnEII4
MYDX at MEDMEN Headquarters. Quote 'MYDX it’s gonna be a great year'
https://www.instagram.com/p/BtMvBI8AbuB/
MYDX Eco Smart Pen and app picture: I guess this picture doesn't exist either. LMAO.
https://investorshub.advfn.com/uimage/uploads/2018/9/10/cssxwCOINS2.PNG
How's this picture http://sharc-research.org/2018/10/16/sharc-student-andrew-fiore-to-use-portable-marijuana-analyzer-in-pilot-study/ showing a STUDENT AT UNIVERSITY OF FLORIDA holding a CannaDx tester with the quote of
'We are excited to share that student Andrew Fiore will be pursuing the use of the CannaDx sensor in a limited pilot study to evaluate the interest of marijuana analyzers in research participants!
This project highlights SHARC’s leading research that works to answer pressing questions about marijuana use. We are excited to see to follow Andrew’s progress.
The use of this device should not be viewed as an endorsement or validation of the CannaDx sensor by SHARC or the University of Florida'
But I guess non believers could say thats not a real person or not a real CannaDx tester in his hand. Alleged Very FUNNY....
SAN DIEGO, CA, Sept. 28, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE - MyDx, Inc. (OTC: MYDX), a leader in science based cannabis health technologies, is proud to announce that the University of Florida will be using our flagship product, the CannaDx Analyzer, in the largest prospective study to date focused on the health effects of marijuana in people living with HIV.
“With this study, we are taking an additional step in solidifying our position as a leader in science based cannabis health technologies. The CannaDx Analyzer is expected to be used in a large pre-clinical long term cannabis study that will track patient data,” stated Daniel Yazbeck, CEO of MyDx. “The science of cannabis is still in its infancy. Studies like these, conducted by reputable institutions like the University of Florida, and supported by MyDx, are paving the way for the future of cannabis science in this country.”
We first entered communications with the University of Florida back in December of 2017. After reviewing the CannaDx Analyzer’s specifications, abilities, and corresponding software application, we are happy to announce that our platform was the one selected for the study.
This is intended to be a long-term study to be conducted over the course of up to 5 years that has the potential to produce valuable data which could contribute to the future possibilities of cannabis being used as a real medicine.
Marijuana and Potential Long-term Effects Study Goals
The overarching goals of this study are to obtain evidence regarding the influence of marijuana on major health outcomes and behavior in persons living with HIV in order to help guide clinical recommendations and identify risk factors for consequences. The research team is especially interested in the relationship of marijuana to novel aspects of cognitive function (e.g. motivation, intention, planning) and to systemic inflammation.
The study will enroll 480 total participants, including 360 marijuana users and 120 non-users. Participants will be asked to complete a baseline visit, with yearly follow-up visits for up to five years.
During a visit, participants will be asked to:
Give a small blood sample
Give a small urine sample
Complete a 45-minute survey about their marijuana, alcohol, and drug use, sexual activity, pain levels, and mood
Complete approximately 2 hours of thinking and memory tasks on paper and on an iPad
The study would like to ask the participants to analyze the marijuana product that they consume using the MyDx device. This will be done by allowing participants to take the device home with a study phone that has the app on it to do a one-time test of their marijuana product. They will also enter some information in the app associated with their marijuana use (e.g., ailments trying to relieve, side effects).
The findings will inform HIV treatment providers and patients who are considering marijuana to manage HIV-related symptoms or the HIV disease itself, and will identify patterns of marijuana use that are most strongly associated with the incidence of substance use disorders.
The application of the MyDx analyzer in this study further solidifies our positioning of the company for a future exit.
So out of 8700 plus views of the video, you printed 3 negative reviews out of 7 total reviews, out of a possible EIGHT THOUSAND SEVEN HUNDRED PLUS VIEWS. Looks like to me then the other 8,697 plus viewers saw no issues with the mydx device.
I'm waiting on the South African updates for MYDX. LMAO.
2 Different Ganga Gold videos: Saying stay tuned for MYDX Pen. 132 views so far.
I don't really care about any comments from mydx posters. Here is the proof of what I said the video was dated. Try doing some DD yourself. Also I could care less what the date is, MYDX IS COMING and IT CANNOT BE STOPPED.
MyDx Review by Slink Johnson at High Times Cannabis Cup - Mclip.tv
https://mclip.tv/video/.../mydx-review-by-slink-johnson-at-high-times-cannabis-cup
? 6:24
Apr 28, 2019 - Uploaded by MyDx Life
MyDx Review by Slink Johnson at High Times Cannabis Cup, ... Similar videos. John Doe ... MyDX Portable ...
You've visited this page 3 times. Last visit: 5/20/19
MYDX VIDEO: almost 35,000 views, but no body is watching, lol. https://mclip.tv/video/g6yj281aNig/mydx-portable-cannabis-tester
This video is dated April 28, 2019. I have never seen it before. https://mclip.tv/video/gTLqyHPtirU/mydx-review-by-slink-johnson-at-high-times-cannabis-cup
This looks new to me, never seen it before. It does look like it may still be being modified. https://www.mydxlife.com/service/mydx-mobile-app-for-cannabis/
MYDXLIFE website traffic numbers up again. Todays numbers: mydxlife.com has received an estimated 22,500 visits over the last 30 days.
I guess that had to be a 'BUY' that made MYDX GREEN now.
HAY, what happened. Why is MYDX GREEN. I wonder if that South African person knows something. LOL. IT'S COMING!!
2 Different Ganga Gold videos: Saying stay tuned for MYDX Pen. 127 views so far.
How's this picture http://sharc-research.org/2018/10/16/sharc-student-andrew-fiore-to-use-portable-marijuana-analyzer-in-pilot-study/ showing a STUDENT AT UNIVERSITY OF FLORIDA holding a CannaDx tester with the quote of
'We are excited to share that student Andrew Fiore will be pursuing the use of the CannaDx sensor in a limited pilot study to evaluate the interest of marijuana analyzers in research participants!
This project highlights SHARC’s leading research that works to answer pressing questions about marijuana use. We are excited to see to follow Andrew’s progress.
The use of this device should not be viewed as an endorsement or validation of the CannaDx sensor by SHARC or the University of Florida'
But I guess non believers could say thats not a real person or not a real CannaDx tester in his hand. Alleged Very FUNNY....
SAN DIEGO, CA, Sept. 28, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE - MyDx, Inc. (OTC: MYDX), a leader in science based cannabis health technologies, is proud to announce that the University of Florida will be using our flagship product, the CannaDx Analyzer, in the largest prospective study to date focused on the health effects of marijuana in people living with HIV.
“With this study, we are taking an additional step in solidifying our position as a leader in science based cannabis health technologies. The CannaDx Analyzer is expected to be used in a large pre-clinical long term cannabis study that will track patient data,” stated Daniel Yazbeck, CEO of MyDx. “The science of cannabis is still in its infancy. Studies like these, conducted by reputable institutions like the University of Florida, and supported by MyDx, are paving the way for the future of cannabis science in this country.”
We first entered communications with the University of Florida back in December of 2017. After reviewing the CannaDx Analyzer’s specifications, abilities, and corresponding software application, we are happy to announce that our platform was the one selected for the study.
This is intended to be a long-term study to be conducted over the course of up to 5 years that has the potential to produce valuable data which could contribute to the future possibilities of cannabis being used as a real medicine.
Marijuana and Potential Long-term Effects Study Goals
The overarching goals of this study are to obtain evidence regarding the influence of marijuana on major health outcomes and behavior in persons living with HIV in order to help guide clinical recommendations and identify risk factors for consequences. The research team is especially interested in the relationship of marijuana to novel aspects of cognitive function (e.g. motivation, intention, planning) and to systemic inflammation.
The study will enroll 480 total participants, including 360 marijuana users and 120 non-users. Participants will be asked to complete a baseline visit, with yearly follow-up visits for up to five years.
During a visit, participants will be asked to:
Give a small blood sample
Give a small urine sample
Complete a 45-minute survey about their marijuana, alcohol, and drug use, sexual activity, pain levels, and mood
Complete approximately 2 hours of thinking and memory tasks on paper and on an iPad
The study would like to ask the participants to analyze the marijuana product that they consume using the MyDx device. This will be done by allowing participants to take the device home with a study phone that has the app on it to do a one-time test of their marijuana product. They will also enter some information in the app associated with their marijuana use (e.g., ailments trying to relieve, side effects).
The findings will inform HIV treatment providers and patients who are considering marijuana to manage HIV-related symptoms or the HIV disease itself, and will identify patterns of marijuana use that are most strongly associated with the incidence of substance use disorders.
The application of the MyDx analyzer in this study further solidifies our positioning of the company for a future exit.
MYDX interview where Daniel says MYDX has a smart pen and mydx created a smart pen for Mr.Cannibas.
CFN Media Interviews MyDx Inc. (MYDX) at NCIA 2018 https://www.cannabisfn.com/cfnvideo/?id=lXSj78HA
MYDX Eco Smart Pen and app picture: I guess this picture doesn't exist either. LMAO.
https://investorshub.advfn.com/uimage/uploads/2018/9/10/cssxwCOINS2.PNG
MYDX at MEDMEN Headquarters. Quote 'MYDX it’s gonna be a great year'
https://www.instagram.com/p/BtMvBI8AbuB/
Wonder if that someone is from South Africa, LOL.
MYDX/Ganja Gold party COMING SOON!
LMAO, another case against MYDX, lol. It must be huge since it's in SMALL CLAIMS COURT and why does the address given say the filer resides is California and you say he's from South Africa. Another scam lawsuit.
The Dewald/Sanzeri case "HAS NOT BEEN DISMISSED" per 10k dated 04/25/19.
Lawsuit Against Jerome Dewald and Skip Sanzeri
As previously disclosed, in July 2017, the Company and its CEO (collectively, the “Plaintiffs”) filed a lawsuit against Jerome Dewald and Skip Sanzeri. On or about July 9, 2018, the Company settled with Mr. Dewald and has dismissed the matter with prejudice as to Mr. Dewald. On or about July 25, 2018, the Company settled with Mr. Sanzeri, which settlement calls for settlement payments of $1,000 per month over the course of five months, after which the Company will dismiss the matter as to Mr. Sanzeri and fully dispose of the lawsuit. As of April 23, 2019, all five $1,000 payments have been made to the Company and the matter has not yet been dismissed.
MYDX NUMBER 3 on Most Posted Cannabis Stocks, MOVIN ON UP!!
The Dewald/Sanzeri case "HAS NOT BEEN DISMISSED" per 10k dated 04/25/19.
Lawsuit Against Jerome Dewald and Skip Sanzeri
As previously disclosed, in July 2017, the Company and its CEO (collectively, the “Plaintiffs”) filed a lawsuit against Jerome Dewald and Skip Sanzeri. On or about July 9, 2018, the Company settled with Mr. Dewald and has dismissed the matter with prejudice as to Mr. Dewald. On or about July 25, 2018, the Company settled with Mr. Sanzeri, which settlement calls for settlement payments of $1,000 per month over the course of five months, after which the Company will dismiss the matter as to Mr. Sanzeri and fully dispose of the lawsuit. As of April 23, 2019, all five $1,000 payments have been made to the Company and the matter has not yet been dismissed
mydxlife.com has received an estimated 22,400 visits over the last 30 days.
That's up 1,000 views from yesterday's number, I know a few were concerned. LOL.
2 Different Ganga Gold videos: Saying stay tuned for MYDX Pen. 125 views so far.
MYDX: Involvement in Legal Proceedings
To the Company’s knowledge, none of our officers or our directors has, during the last ten years:
?
been convicted in a criminal proceeding or been subject to a pending criminal proceeding (excluding traffic violations and other minor offenses);
?
had any bankruptcy petition filed by or against the business or property of the person, or of any partnership, corporation or business association of which he was a general partner or executive officer, either at the time of the bankruptcy filing or within two years prior to that time;
?
been subject to any order, judgment, or decree, not subsequently reversed, suspended or vacated, of any court of competent jurisdiction or federal or state authority, permanently or temporarily enjoining, barring, suspending or otherwise limiting, his involvement in any type of business, securities, futures, commodities, investment, banking, savings and loan, or insurance activities, or to be associated with persons engaged in any such activity;
?
been found by a court of competent jurisdiction in a civil action or by the SEC or the Commodity Futures Trading Commission to have violated a federal or state securities or commodities law, and the judgment has not been reversed, suspended, or vacated;
?
been the subject of, or a party to, any federal or state judicial or administrative order, judgment, decree, or finding, not subsequently reversed, suspended or vacated (not including any settlement of a civil proceeding among private litigants), relating to an alleged violation of any federal or state securities or commodities law or regulation, any law or regulation respecting financial institutions or insurance companies including, but not limited to, a temporary or permanent injunction, order of disgorgement or restitution, civil money penalty or temporary or permanent cease-and-desist order, or removal or prohibition order, or any law or regulation prohibiting mail or wire fraud or fraud in connection with any business entity;
The Dewald/Sanzeri case "HAS NOT BEEN DISMISSED" per 10k dated 04/25/19.
Lawsuit Against Jerome Dewald and Skip Sanzeri
As previously disclosed, in July 2017, the Company and its CEO (collectively, the “Plaintiffs”) filed a lawsuit against Jerome Dewald and Skip Sanzeri. On or about July 9, 2018, the Company settled with Mr. Dewald and has dismissed the matter with prejudice as to Mr. Dewald. On or about July 25, 2018, the Company settled with Mr. Sanzeri, which settlement calls for settlement payments of $1,000 per month over the course of five months, after which the Company will dismiss the matter as to Mr. Sanzeri and fully dispose of the lawsuit. As of April 23, 2019, all five $1,000 payments have been made to the Company and the matter has not yet been dismissed.
2 Different Ganga Gold videos: Saying stay tuned for MYDX Pen. 120 views so far.
25 'DOES' currently - how many MYDX 'DOES' will MYDX have after the slip up of announcing we had a week to go, I guess it's anyone guess or we will see once the deadline of a week passes by.
Here are the details what the 25 Named and UNNAMED 'DOES' did:
10.Plaintiffs are informed and believe and there on allege
that DOES 1 through 12 are persons, corporations or other entities which reside or are authorized to do and are doing business in San Diego, California. The true identities of DOES 1 through 12 are currently unknown to Plaintiffs; therefore,Plaintiffs now sue DOES 1 through 12 by fictitious names. Plaintiffs will amend this Complaint to state the proper names of each Doe Defendant when its identity is discovered.
11.
Plaintiffs are informed and believe and thereon allege
that DOES 13 through 25 are persons, corporations, or other entities which reside or are authorized to do and are
doing business in San Diego, California.The true identities of DOES 13 through 25 are currently unknown to Plaintiffs and therefore Plaintiffs pray for leave to amend this Complaint to assert the proper names of each Doe Defendant when its identity is discovered.
Plaintiff is informed and believes and there on alleges that DOES 13
through 25 were the managerial agent, employee, predecessor, subsidiary successor, joint venturer, co-conspirator, alter ego, and/or representative of each and every other Defendant named herein or identified as DOES 1 through 12, and acted with the permission, authorization and/or ratification and consent of each and every other Defendant at all times relevant herein.
12.
Plaintiffs are informed and believe and there on allege that each fictitiously named Defendant is in some way responsible for, participated in, or contributed to the matters of which Plaintiffs complain of, and has legal responsibility for those matters.
13.
Plaintiffs are informed and believe and there on allege that, at all relevant times, each of the defendants, whether named or fictitious, were the agents or employees of each of the other defendants, and in doing the things alleged to have been done in the complaint, acted within the scope of such agency or employment, or ratified the acts of
the other.
The Dewald/Sanzeri case "HAS NOT BEEN DISMISSED" per 10k dated 04/25/19.
Lawsuit Against Jerome Dewald and Skip Sanzeri
As previously disclosed, in July 2017, the Company and its CEO (collectively, the “Plaintiffs”) filed a lawsuit against Jerome Dewald and Skip Sanzeri. On or about July 9, 2018, the Company settled with Mr. Dewald and has dismissed the matter with prejudice as to Mr. Dewald. On or about July 25, 2018, the Company settled with Mr. Sanzeri, which settlement calls for settlement payments of $1,000 per month over the course of five months, after which the Company will dismiss the matter as to Mr. Sanzeri and fully dispose of the lawsuit. As of April 23, 2019, all five $1,000 payments have been made to the Company and the matter has not yet been dismissed.
NO WHERE in the MYDX lawsuit does it state the charges against the 25 NAMED and UNNAMED Defendants aka'DOES' has been dismissed. I still think the names maybe published in the next upcoming earnings statement.
LMAO. Website traffic count last week was 25,100. It changes daily. I don't post it everyday, but now that I know investors are interested I will post the traffic count daily.
I wonder why the view counts for both Ganga Gold/MYDX video's keep going up every day. MYDX video of Ganga Gold APP(powered by MYDX) started with 3, now 264 in less than a week. More 'EYES' are watching then we think.
2 Different Ganga Gold videos: Saying stay tuned for MYDX Pen. 116 views so far.
The Dewald/Sanzeri case "HAS NOT BEEN DISMISSED" per 10k dated 04/25/19.
Lawsuit Against Jerome Dewald and Skip Sanzeri
As previously disclosed, in July 2017, the Company and its CEO (collectively, the “Plaintiffs”) filed a lawsuit against Jerome Dewald and Skip Sanzeri. On or about July 9, 2018, the Company settled with Mr. Dewald and has dismissed the matter with prejudice as to Mr. Dewald. On or about July 25, 2018, the Company settled with Mr. Sanzeri, which settlement calls for settlement payments of $1,000 per month over the course of five months, after which the Company will dismiss the matter as to Mr. Sanzeri and fully dispose of the lawsuit. As of April 23, 2019, all five $1,000 payments have been made to the Company and the matter has not yet been dismissed.
mydxlife.com has received an estimated 21,100 visits over the last 30 days.
Will the next 10Q list the 25 Named and UNNAMED defendants in the MYDX lawsuit?
How's this picture http://sharc-research.org/2018/10/16/sharc-student-andrew-fiore-to-use-portable-marijuana-analyzer-in-pilot-study/ showing a STUDENT AT UNIVERSITY OF FLORIDA holding a CannaDx tester with the quote of
'We are excited to share that student Andrew Fiore will be pursuing the use of the CannaDx sensor in a limited pilot study to evaluate the interest of marijuana analyzers in research participants!
This project highlights SHARC’s leading research that works to answer pressing questions about marijuana use. We are excited to see to follow Andrew’s progress.
The use of this device should not be viewed as an endorsement or validation of the CannaDx sensor by SHARC or the University of Florida'
But I guess non believers could say thats not a real person or not a real CannaDx tester in his hand. Alleged Very FUNNY....
SAN DIEGO, CA, Sept. 28, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE - MyDx, Inc. (OTC: MYDX), a leader in science based cannabis health technologies, is proud to announce that the University of Florida will be using our flagship product, the CannaDx Analyzer, in the largest prospective study to date focused on the health effects of marijuana in people living with HIV.
“With this study, we are taking an additional step in solidifying our position as a leader in science based cannabis health technologies. The CannaDx Analyzer is expected to be used in a large pre-clinical long term cannabis study that will track patient data,” stated Daniel Yazbeck, CEO of MyDx. “The science of cannabis is still in its infancy. Studies like these, conducted by reputable institutions like the University of Florida, and supported by MyDx, are paving the way for the future of cannabis science in this country.”
We first entered communications with the University of Florida back in December of 2017. After reviewing the CannaDx Analyzer’s specifications, abilities, and corresponding software application, we are happy to announce that our platform was the one selected for the study.
This is intended to be a long-term study to be conducted over the course of up to 5 years that has the potential to produce valuable data which could contribute to the future possibilities of cannabis being used as a real medicine.
Marijuana and Potential Long-term Effects Study Goals
The overarching goals of this study are to obtain evidence regarding the influence of marijuana on major health outcomes and behavior in persons living with HIV in order to help guide clinical recommendations and identify risk factors for consequences. The research team is especially interested in the relationship of marijuana to novel aspects of cognitive function (e.g. motivation, intention, planning) and to systemic inflammation.
The study will enroll 480 total participants, including 360 marijuana users and 120 non-users. Participants will be asked to complete a baseline visit, with yearly follow-up visits for up to five years.
During a visit, participants will be asked to:
Give a small blood sample
Give a small urine sample
Complete a 45-minute survey about their marijuana, alcohol, and drug use, sexual activity, pain levels, and mood
Complete approximately 2 hours of thinking and memory tasks on paper and on an iPad
The study would like to ask the participants to analyze the marijuana product that they consume using the MyDx device. This will be done by allowing participants to take the device home with a study phone that has the app on it to do a one-time test of their marijuana product. They will also enter some information in the app associated with their marijuana use (e.g., ailments trying to relieve, side effects).
The findings will inform HIV treatment providers and patients who are considering marijuana to manage HIV-related symptoms or the HIV disease itself, and will identify patterns of marijuana use that are most strongly associated with the incidence of substance use disorders.
The application of the MyDx analyzer in this study further solidifies our positioning of the company for a future exit.